Skip to content
ΕΛ

KISSPEPTIN-10

Kisspeptin-10

Minimum order 2 vials or 2 pens — delivery in 2 weeks
Two randomized Imperial College studies — one in men and one in women with low sexual desire. In men, erections up to 56% greater than with placebo.

Kisspeptin is the switch above the sex hormones. It activates GnRH neurons in the hypothalamus, those drive the pituitary, and the pituitary releases LH and FSH — testosterone and estrogen.

What's rare here is the quality of the evidence: two randomized, double-blind, placebo-controlled crossover studies — one in men, one in women, both with diagnosed sexual desire disorder.

In men, 32 of 37 completed: kisspeptin modulated activity in the sexual-processing network (P = 0.003), and erections increased by up to 56% more than with placebo (P = 0.02) 1. In women, 32 of 40 completed, with no reported adverse effects and a greater response in those with greater baseline distress (P = 0.007) 2.

And here care is needed: both studies used kisspeptin-54, intravenously, as a continuous 75-minute infusion 12. What's sold here is kisspeptin-10 — same system, different molecule, different route, much shorter half-life.

It's not the same thing that was tested, and we don't present it as such. The short lifespan is a trait, not a flaw — store it properly and use it soon after reconstitution. A research product.

Sources — 2 published studies
  1. Mills EG, Ertl N, Wall MB, et al. Effects of Kisspeptin on Sexual Brain Processing and Penile Tumescence in Men With Hypoactive Sexual Desire Disorder: A Randomized Clinical Trial. JAMA Netw Open. 2023;6(2):e2254313. doi:10.1001/jamanetworkopen.2022.54313
  2. Thurston L, Hunjan T, Ertl N, et al. Effects of Kisspeptin Administration in Women With Hypoactive Sexual Desire Disorder: A Randomized Clinical Trial. JAMA Netw Open. 2022;5(10):e2236131. doi:10.1001/jamanetworkopen.2022.36131

Kisspeptin is the master switch above testosterone and estrogen — it signals the hypothalamus, which drives the pituitary, which releases LH and FSH.

And there's something rare for this space: two randomized, double-blind, placebo-controlled studies — one in men, one in women.

In men (32 of 37 completed): erections went up to 56% above placebo (P = 0.02), with increased reported satisfaction 1. In women (32 of 40): no adverse effects, and the greater the baseline distress, the greater the response (P = 0.007) 2.

Straight talk: these numbers come from kisspeptin-54, intravenous, as a continuous 75-minute infusion 12. What you get is kisspeptin-10 — same receptor, different molecule, and it clears from the blood much faster.

We're not telling you it's the same thing that was tested — it's the same system. A short lifespan means proper storage and quick use after reconstitution. Research, not a guaranteed result.

Sources — 2 published studies
  1. Mills EG, Ertl N, Wall MB, et al. Effects of Kisspeptin on Sexual Brain Processing and Penile Tumescence in Men With Hypoactive Sexual Desire Disorder: A Randomized Clinical Trial. JAMA Netw Open. 2023;6(2):e2254313. doi:10.1001/jamanetworkopen.2022.54313
  2. Thurston L, Hunjan T, Ertl N, et al. Effects of Kisspeptin Administration in Women With Hypoactive Sexual Desire Disorder: A Randomized Clinical Trial. JAMA Netw Open. 2022;5(10):e2236131. doi:10.1001/jamanetworkopen.2022.36131

The switch that sits above all the sex hormones.

Kisspeptin is the peptide that gives the start signal: it activates GnRH neurons in the hypothalamus, those drive the pituitary, and the pituitary releases LH and FSH — in other words, testosterone and estrogen. It's not a sex hormone. It's the switch above them.

And here something happened that rarely happens in this space: two randomized, double-blind, placebo-controlled crossover studies — one in men, one in women.

In men. 37 were randomized, 32 completed, mean age 37.9 years, all with diagnosed hypoactive sexual desire disorder. While viewing sexual stimuli, kisspeptin modulated activity in key structures of the sexual-processing network (Cohen d = 0.81; P = 0.003). And it didn't stop at brain imaging: erections increased by up to 56% more than with placebo (P = 0.02), and self-reported happiness about sex went up (P = 0.02) 1.

In women, from the same team, with the same protocol. 40 premenopausal women with the same diagnosis, 32 completed. Kisspeptin altered the processing of both erotic stimuli and facial attractiveness. And the most interesting finding of the whole study: the greater each woman's distress about her sexual function at baseline, the greater the enhancement in her hippocampus (r = 0.469; P = 0.007). In other words, it worked more where the problem was actually there. No adverse effects were reported 2.

Now the “but”, and it's a serious one — don't skip it. Both studies used kisspeptin-54, intravenously, as a continuous 75-minute infusion 12. What's sold here is kisspeptin-10: the short active end of the same molecule, same receptor — but a different molecule, a different route, a much shorter half-life. The reason the researchers set up a seventy-five-minute infusion is exactly this: kisspeptin clears fast.

It's not the same thing as what was tested, and we won't tell you it is. It's the same system.

Sources — 2 published studies
  1. Mills EG, Ertl N, Wall MB, et al. Effects of Kisspeptin on Sexual Brain Processing and Penile Tumescence in Men With Hypoactive Sexual Desire Disorder: A Randomized Clinical Trial. JAMA Netw Open. 2023;6(2):e2254313. doi:10.1001/jamanetworkopen.2022.54313
  2. Thurston L, Hunjan T, Ertl N, et al. Effects of Kisspeptin Administration in Women With Hypoactive Sexual Desire Disorder: A Randomized Clinical Trial. JAMA Netw Open. 2022;5(10):e2236131. doi:10.1001/jamanetworkopen.2022.36131

Both studies concern intravenous kisspeptin-54. The product is kisspeptin-10 — same receptor, different molecule, different route.

Frequently asked questions

Which packs is Kisspeptin-10 available in?

Vial: 10 mg vial · Pens: 1 × 10 mg pen.

Is Kisspeptin-10 in stock?

We don't keep it in stock — it's ordered in: minimum 2 items (vials or pens) from the special-order products, with free shipping, and it arrives in about 2 weeks.

How much is shipping?

€3 shipping + €3 cash-on-delivery fee. For orders of 2 vials or pens or more, shipping and the cash-on-delivery fee are free. Delivery time depends on the courier.

How do I pay?

Cash on delivery, paid to the courier when it arrives. For an electronic money transfer (PayPal, Revolut, Wise, crypto), email us for the details: ellinikapeptidia@gmail.com

Can I return it?

Yes: you have a 14-day right of withdrawal from delivery, as long as the seal is intact. Return costs are yours, unless the product was faulty or wrong. Terms of Use

Want something you don't see here? Write to us — we reply.

Related products

From the same category

Semax
SEMAX

Semax

from €26.40 to €101.60

Minimum order 2 vials or 2 pens — delivery in 2 weeks

A piece of ACTH — amino acids 4 to 10 — without the hormonal action. In 52 healthy volunteers, fMRI showed it changed right amygdala connectivity within 20 minutes.

2 studies
Pack
0
Selank
SELANK

Selank

from €24.80 to €96.80

Minimum order 2 vials or 2 pens — delivery in 2 weeks

An analog of tuftsin — an immune peptide, not a sedative. In Russia it has passed phase III as a selective anxiolytic; in the one study you can actually read, it acts on the amygdala.

3 studies
Pack
0
Oxytocin
OXYTOCIN

Oxytocin

from €29.60 to €66.40

Minimum order 2 vials or 2 pens — delivery in 2 weeks

The “love hormone.” A meta-analysis of 17 randomized trials with 466 participants found an effect size of 0.08 on emotion recognition. In other words, nothing.

2 studies
Pack
0
DSIP
DSIP

DSIP

from €29.60 to €58.40

Minimum order 2 vials or 2 pens — delivery in 2 weeks

Delta sleep-inducing peptide. The name promises sleep. A 2006 review calls it an “unresolved riddle” — the gene, the protein and the receptor were never found.

1 study
Pack
0
Pinealon
PINEALON

Pinealon

from €23.20 to €82.40

Minimum order 2 vials or 2 pens — delivery in 2 weeks

Pineal/CNS tripeptide (Glu-Asp-Arg): in hippocampal neurons in an amyloid toxicity model, EDR increased mature dendritic spines by 71%.

1 study
Pack
0
PE-22-28
PE-22-28

PE-22-28

from €23.20 to €63.20

Minimum order 2 vials or 2 pens — delivery in 2 weeks

Spadin analog and TREK-1 channel inhibitor: it inhibited TREK-1 with an IC50 of 0.12 nM (vs 40–60 nM for spadin) and reduced immobility in the forced swim test.

1 study
Pack
0